These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 33507540)
21. HIV associated high-risk HPV infection among Nigerian women. Akarolo-Anthony SN; Al-Mujtaba M; Famooto AO; Dareng EO; Olaniyan OB; Offiong R; Wheeler CM; Adebamowo CA BMC Infect Dis; 2013 Nov; 13():521. PubMed ID: 24192311 [TBL] [Abstract][Full Text] [Related]
22. High-risk human papillomavirus infection among Nigerian women: A systematic review and meta-analysis. Ezechi O; Akinsolu F; Salako A; Abodunrin O; Adewole I; Olagunju M; Okunbor H; Sanni-Adeniyi R; Zamba E; Njuguna DW; Eleje G J Int Med Res; 2023 Jul; 51(7):3000605231182884. PubMed ID: 37409466 [TBL] [Abstract][Full Text] [Related]
23. Prevalence of high-risk human papilloma virus types and cervical smear abnormalities in female sex workers in Chandigarh, India. Singh MP; Kaur M; Gupta N; Kumar A; Goyal K; Sharma A; Majumdar M; Gupta M; Ratho RK Indian J Med Microbiol; 2016; 34(3):328-34. PubMed ID: 27514955 [TBL] [Abstract][Full Text] [Related]
24. hrHPV prevalence and type distribution in rural Zimbabwe: A community-based self-collection study using near-point-of-care GeneXpert HPV testing. Fitzpatrick MB; Dube Mandishora RS; Katzenstein DA; McCarty K; Weber J; Sahoo MK; Manasa J; Chirenje ZM; Pinsky BA Int J Infect Dis; 2019 May; 82():21-29. PubMed ID: 30807869 [TBL] [Abstract][Full Text] [Related]
25. The distribution of hrHPV genotypes among cervical cancer cases diagnosed across Ghana: a cross-sectional study. Akakpo PK; Imbeah EG; Ulzen-Appiah K; Darkwa-Abrahams A; Adjei E; Amo-Antwi K; Amo EO; Der EM; Wiredu EK BMC Infect Dis; 2024 Mar; 24(1):356. PubMed ID: 38539128 [TBL] [Abstract][Full Text] [Related]
26. High-risk human papillomavirus prevalence in self-collected cervicovaginal specimens from human immunodeficiency virus (HIV)-negative women and women living with HIV living in Botswana. Castle PE; Varallo JE; Bertram MM; Ratshaa B; Kitheka M; Rammipi K PLoS One; 2020; 15(2):e0229086. PubMed ID: 32053659 [TBL] [Abstract][Full Text] [Related]
27. HPV-based screening for cervical cancer among women 55-59 years of age. Bergengren L; Lillsunde-Larsson G; Helenius G; Karlsson MG PLoS One; 2019; 14(6):e0217108. PubMed ID: 31199811 [TBL] [Abstract][Full Text] [Related]
28. High prevalence of abnormal cervical smears in a hospital cohort of French women beyond the upper age limit screening program. Luquain A; Belglaiaa E; Guenat D; Vrecko S; Riethmuller D; Valmary-Degano S; Bedgedjian I; Chouham S; Prétet JL; Mougin C Prev Med; 2015 Dec; 81():157-62. PubMed ID: 26348451 [TBL] [Abstract][Full Text] [Related]
29. Prevalence and Genotype Distribution of Human Papillomavirus in Invasive Cervical Cancer, Cervical Intraepithelial Neoplasia, and Asymptomatic Women in Southeast China. Wang X; Zeng Y; Huang X; Zhang Y Biomed Res Int; 2018; 2018():2897937. PubMed ID: 30402468 [TBL] [Abstract][Full Text] [Related]
30. A Head-to-Head Analytical Comparison of Cobas 4800 HPV, PapilloCheck HPV Screening, and LMNX Genotyping Kit HPV GP for Detection of Human Papillomavirus DNA in Cervical and Cervicovaginal Swabs. Jaworek H; Koudelakova V; Drabek J; Vrbkova J; Zborilova B; Oborna I; Brezinova J; Marek R; Huml K; Vanek P; Hajduch M J Mol Diagn; 2018 Nov; 20(6):849-858. PubMed ID: 30165205 [TBL] [Abstract][Full Text] [Related]
31. Population-based evaluation of type-specific HPV prevalence among women in British Columbia, Canada. Ogilvie GS; Cook DA; Taylor DL; Rank C; Kan L; Yu A; Mei W; van Niekerk DJ; Coldman AJ; Krajden M Vaccine; 2013 Feb; 31(7):1129-33. PubMed ID: 23273510 [TBL] [Abstract][Full Text] [Related]
32. Prevalence of human papillomavirus infection among women presenting for cervical cancer screening in Chile, 2014-2015. Balanda M; Quiero A; Vergara N; Espinoza G; Martín HS; Rojas G; Ramírez E Med Microbiol Immunol; 2016 Dec; 205(6):585-594. PubMed ID: 27539577 [TBL] [Abstract][Full Text] [Related]
33. Prevalence of high-risk human papillomavirus and abnormal pap smears in female sex workers compared to the general population in Antwerp, Belgium. Vorsters A; Cornelissen T; Leuridan E; Bogers J; Vanden Broeck D; Benoy I; Goossens H; Hens N; Van Damme P BMC Public Health; 2016 Jun; 16():477. PubMed ID: 27266509 [TBL] [Abstract][Full Text] [Related]
34. Vaginal high-risk human papillomavirus infection in a cross-sectional study among women of six different ethnicities in Amsterdam, the Netherlands: the HELIUS study. Alberts CJ; Vos RA; Borgdorff H; Vermeulen W; van Bergen J; Bruisten SM; Geerlings SE; Snijder MB; van Houdt R; Morré SA; de Vries HJ; van de Wijgert JH; Prins M; Schim van der Loeff MF Sex Transm Infect; 2016 Dec; 92(8):611-618. PubMed ID: 27188273 [TBL] [Abstract][Full Text] [Related]
35. Prevalence of human papillomavirus genotypes in women with cervical cancer in Papua New Guinea. Tabone T; Garland SM; Mola G; O'Connor M; Danielewski J; Tabrizi SN Int J Gynaecol Obstet; 2012 Apr; 117(1):30-2. PubMed ID: 22325971 [TBL] [Abstract][Full Text] [Related]
36. Genital human papillomavirus infection in women from the Zagreb region. Marijan T; Vranes J; Mlinarić-Dzepina A; Leskovar V; Knezević J; Kvaternik M Coll Antropol; 2007 Apr; 31 Suppl 2():83-7. PubMed ID: 17600936 [TBL] [Abstract][Full Text] [Related]
37. HPV Testing for Cervical Cancer in Romania: High-Risk HPV Prevalence among Ethnic Subpopulations and Regions. Ilisiu MB; Hashim D; Andreassen T; Støer NC; Nicula F; Weiderpass E Ann Glob Health; 2019 Jun; 85(1):. PubMed ID: 31225959 [TBL] [Abstract][Full Text] [Related]
38. Prevalence of cervical human papillomavirus infection in healthy women is related to sexual behaviours and educational level: a cross-sectional study. Tay SK; Oon LL Int J STD AIDS; 2014 Dec; 25(14):1013-21. PubMed ID: 24648316 [TBL] [Abstract][Full Text] [Related]
39. Prevalence of high-risk human papillomavirus infection among women in Shaanxi province of China: A hospital-based investigation. Cao D; Zhang S; Zhang Q; Wei X; Zhao M; Ma Q; Li Y; Wang L; Pei M; Yang T; Zhao J; Yang X J Med Virol; 2017 Jul; 89(7):1281-1286. PubMed ID: 27935120 [TBL] [Abstract][Full Text] [Related]
40. HLA-DP is the cervical cancer susceptibility loci among women infected by high-risk human papillomavirus: potential implication for triage of human papillomavirus-positive women. Jia M; Han J; Hang D; Jiang J; Wang M; Wei B; Dai J; Zhang K; Guo L; Qi J; Ma H; Shi J; Ren J; Hu Z; Dai M; Li N Tumour Biol; 2016 Jun; 37(6):8019-25. PubMed ID: 26711785 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]